Cromwell Holdings’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$117K Sell
1,482
-2,752
-65% -$222K 0.05% 311
2026
Q1
$370K Hold
4,234
0.21% 98
2025
Q4
$410K Hold
4,234
0.22% 85
2025
Q3
$406K Hold
4,234
0.22% 86
2025
Q2
$372K Buy
4,234
+205
+5% +$17.4K 0.23% 88
2025
Q1
$362K Buy
4,029
+1,736
+76% +$155K 0.23% 88
2024
Q4
$183K Sell
2,293
-611
-21% -$52.9K 0.11% 170
2024
Q3
$263K Sell
2,904
-1,455
-33% -$122K 0.17% 120
2024
Q2
$346K Buy
+4,359
New +$357K 0.21% 88

Other funds holding MDT

Cromwell Holdings's MDT Position: Q2 2026 in Review

Cromwell Holdings reduced its Medtronic (MDT) stake by 65% in Q2 2026, selling an estimated $222K and leaving 1,482 shares worth $117K. The position accounts for 0.05% of the portfolio, ranked #311.

Cromwell Holdings first reported a position in MDT in Q2 2024 and has held it in 9 quarters since. The position peaked at $410K in Q4 2025. 372 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Cromwell Holdings held 1,482 shares of Medtronic worth $117K as of Q2 2026.
  • Cromwell Holdings sold 2,752 Medtronic shares in Q2 2026, an estimated $222K.
  • Medtronic made up 0.05% of Cromwell Holdings's portfolio in Q2 2026, its #311 holding.
  • Cromwell Holdings first reported a position in Medtronic in Q2 2024 and has held it in 9 quarters since.
  • Cromwell Holdings's Medtronic position peaked at $410K in Q4 2025.
  • 372 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.